Compound ID | 825
Class: Oxazolidinone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor |
| Institute where first reported: | Pharmacia Corp. and Veriscor (Pfizer, USA) |
| Year first mentioned: | 2001 |
| Development status: | Experimental |
| External links: |